has served on scientific advisory panels and/or speaker's bureaus and served as a consultant to and/or received research support from Amgen, AstraZeneca, Boehringer Ingelheim, Eli Lilly, Fractyl, Gubra, Merck Sharp & Dohme, Novo Nordisk, Sanofi and Zealand Pharma
Intensified, multifactorial treatment to therapeutic goals (targeting glycemic control, blood pressure, lipid levels, and renal function) has been associated with a reduction in cardiovascular and microvascular complications (27)
The benefits of Semaglutide treatment extend beyond just weight loss and diabetes management
We did not identify any study that specifically addressed potential interactions between GLP-1RAs and frequently used antidepressant medications
So to get it approved by your insurance company or another payer, you often need that criteria
Her goal is not just to help patients lose weight, but to help them thrive with improved energy, balanced hormones, and renewed confidence in their health